Scandinavian Astor Group AB (”Astor Group”, ”Koncernen” eller ”Bolaget”) har flyttat fram positionen...
CapMan announced today that it has signed an agreement to sell its ownership of CapMan Procurement S...
Q3'24e organic sales growth of 24% y-o-y Minor positive estimate revisions FVR of SEK 25-40 reiterat...
Redeye gives a comment on today’s news that IRLAB has successfully completed the first part of the p...
Scanfil acquired two factories (SRXGlobal) for EUR 23m.
IRLAB Therapeutics has announced an encouraging update for the ongoing Phase I trial for IRL757, whi...
Redeye takes a positive stance towards the acquisition of Visual Art.
Redeye provides a short research update following the outcome of the TO3 warrants recently published...
Endomines’ Q3 production was fairly well in line with our estimates at 4,191 ounces (Evli est.
Last night, Climeon announced a directed share issue of SEK50m adding about a year of runway in our ...
AcuCort (”AcuCort” eller ”Bolaget”) meddelade den 2 oktober år 2024 att Bolaget har beviljats förlän...
Odinwell står inför en betydande marknadsmöjlighet inom sårvård med sin innovativa teknologi.
Redsense presenterar ett starkt andra kvartal med en rekordomsättning.
New targets ahead of CMD at 13:00 CET 14% 5Y sales CAGR, 6% EBIT margin,
Refine Group AB (”Refine”, ”Koncernen” eller ”Bolaget”) meddelade den 30 september år 2024 att dotte...
Redeye endorses the news that Egetis has finalized a directed issue of some SEK300m to new and exist...
Redeye has updated its fair value range for Lifecare following the company's reverse share split, a ...
Duell publishes its Q4 (6-8/24) figures on Wednesday 9th of October.
Redeye comments on the news that the CEO is departing the company.
Redeye updates its estimates for the Q3 2024 report (due 2024-10-25).